PM

Partha Mishra

Partner at DNA Capital; Board Member; Former President & CEO

Atlanta Metropolitan Area

Invests in

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $2,500,000.00

Skills

Scaling Tech-Enabled, High-Impact Service Platforms
Enterprise and Consumer Digital Health Technology
Strategy & Transformation
Leadership
Health Care Enterprise Technology
Digital Health Technology
Healthcare Technology & Business Services
Leadership for Scaling Service Business

Work Experience

  • Partner

    2019

    Backed by the leading healthcare business conglomerate from Latin America and marquee global institutional investors, DNA Capital partners with and empowers exceptional founders and management teams across stages to build disruptive, high-growth, health-tech businesses for the greatest common good.

  • Board Member

    2022

  • Board Observer

    2021

2021 - 2023

  • Board Member

    2021 - 2023

2007 - 2019

  • President & CEO, Optum Global Solutions, A UnitedHealth Group Company

    2007 - 2019

    Optum Global Solutions is the enterprise technology, engineering, and business solutions arm of Optum, a UnitedHealth Group company serving the US healthcare marketplace. Led strategy, growth, and execution for the $1 billion business unit delivering enterprise-grade commercial and internal software, data solutions, and healthcare services to Group companies and external customers including payers, employers, providers, and pharmacy benefit management companies.

2002 - 2007

  • Vice President, Healthcare

    2002 - 2007

    P&L owner for $145 million healthcare business; cultivated the first $100 million relationship for the firm; led strategy and growth for healthcare industry vertical which accounted for 19% of the firm’s revenue by 2007; successfully on-boarded several important clients to sustain and accelerate growth; beat revenue target 5 years in a row.

1996 - 2002

  • Senior Manager

    1996 - 2002

    Led the P&L for Supply Chain Transformation practice for the Life Sciences industry in the US.